Axsome Therapeutics Inc (AXSM) — Capital Reinvestment Ratio

Latest as of September 2025: 0.06x

Axsome Therapeutics Inc (AXSM) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow ($1.05 Million) in capital expenditures ($58.00K). Check AXSM goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

$1.05 Million

USD

Capital Expenditures

$58.00K

USD

Data as of

Sep 2025

Most recent filing

Annual Capital Reinvestment Ratio for Axsome Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Axsome Therapeutics Inc from None to None. See free cash flow generation of Axsome Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow